TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective Randomized Multicentric Trial Comparing Amoxicillin/Clavulanate Potassium Therapy to Appendectomy for Acute Non Complicated Appendicitis
Brief Summary: The purpose of the study is to demonstrate that antibiotic therapy is as safe and effective as appendectomy for the treatment of acute non complicated appendicitis. Two hundred fifty patients will be included in a prospective multicentric randomized trial. The primary endpoint is the rate of intra abdominal infections in both therapeutic strategies. Other criteria will be studied including duration of hospital stay and absence from work during a follow up period of one year, parietal and abdominal complications and recurrent appendicitis after antibiotic therapy.


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Procedure: appendectomy | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: amoxicillin/clavulanate potassium | Intervention Type: DRUG; Name: amoxicillin/clavulanate potassium; Assigned to Arm(s): B | Intervention Type: PROCEDURE; Name: appendectomy; Assigned to Arm(s): A
B: Arm Label: Low-dose CT; Type: EXPERIMENTAL; Interventions: Radiation: Diagnostic CT | Arm Label: Standard-dose CT; Type: ACTIVE_COMPARATOR; Interventions: Radiation: Diagnostic CT | Intervention Type: RADIATION; Name: Diagnostic CT; Assigned to Arm(s): Low-dose CT | Intervention Type: RADIATION; Name: Diagnostic CT; Assigned to Arm(s): Standard-dose CT
C: Arm Label: Operative treatment; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Appendicectomy | Arm Label: Antibiotic treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ertapenem | Intervention Type: PROCEDURE; Name: Appendicectomy; Assigned to Arm(s): Operative treatment | Intervention Type: DRUG; Name: Ertapenem; Assigned to Arm(s): Antibiotic treatment
D: Arm Label: Low-dose CT; Type: EXPERIMENTAL; Interventions: Diagnostic Test: Diagnostic CT with low-dose radiation | Arm Label: Standard-dose CT; Type: ACTIVE_COMPARATOR; Interventions: Diagnostic Test: Diagnostic CT with standard-dose radiation | Intervention Type: DIAGNOSTIC_TEST; Name: Diagnostic CT with low-dose radiation; Assigned to Arm(s): Low-dose CT | Intervention Type: DIAGNOSTIC_TEST; Name: Diagnostic CT with standard-dose radiation; Assigned to Arm(s): Standard-dose CT

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Place of Low-Dose Naltrexone in Opiate Detoxification
Brief Summary: There is a continuing search for more effective opiate detoxification treatments. This study's purpose is to investigate the effects of adding very low doses of naltrexone to a methadone tapering treatment in opioid dependent individuals.


Options:
A: Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): N/A
B: Arm Label: Group 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo comparator | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Naltrexone | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Naltrexone | Intervention Type: DRUG; Name: Naltrexone; Assigned to Arm(s): 2, 3 | Intervention Type: DRUG; Name: Placebo comparator; Assigned to Arm(s): Group 1 | Intervention Type: DRUG; Name: naltrexone; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: naltrexone; Assigned to Arm(s): 3
C: Intervention Type: DRUG; Name: Buprenorphine/naloxone; Assigned to Arm(s): N/A
D: Arm Label: Buprenorphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Buprenorphine, Drug: Vivitrol | Arm Label: Oral naltrexone; Type: ACTIVE_COMPARATOR; Interventions: Drug: oral naltrexone, Drug: Buprenorphine, Drug: Vivitrol | Intervention Type: DRUG; Name: oral naltrexone; Assigned to Arm(s): Oral naltrexone | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Buprenorphine, Oral naltrexone | Intervention Type: DRUG; Name: Vivitrol; Assigned to Arm(s): Buprenorphine, Oral naltrexone

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial of Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in Pregnancies at High Risk
Brief Summary: A recently completed trial of weekly injections of 17 alpha hydroxyprogesterone caproate (17P) found significant effectiveness for 17P in preventing recurrent preterm birth. However, the group who received 17P in this trial still had a high rate of preterm birth. Several reports have shown that dietary supplementation of fish oil, which is rich in Omega-3 fatty acids, reduces the risk of preterm birth. This trial tests whether adding the Omega-3 supplement to 17P therapy has the potential for further reducing the risk of preterm birth in women who have previously had a spontaneous preterm delivery. The trial will compare Omega-3 fatty acid with placebo in women receiving 17P therapy. The hypothesis being tested is: "Among women at high risk for preterm birth receiving weekly injections of 17P, the addition of Omega-3 nutritional supplement will further reduce the rate of preterm birth."


Options:
A: Arm Label: 17P plus Omega-3 Supplement; Type: ACTIVE_COMPARATOR; Interventions: Drug: 17 alpha-Hydroxyprogesterone Caproate and Omega-3 supplement | Arm Label: 17P plus Placebo Supplement; Type: PLACEBO_COMPARATOR; Interventions: Drug: 17 alpha-hydroxy progesterone caproate and Placebo supplement | Intervention Type: DRUG; Name: 17 alpha-Hydroxyprogesterone Caproate and Omega-3 supplement; Assigned to Arm(s): 17P plus Omega-3 Supplement | Intervention Type: DRUG; Name: 17 alpha-hydroxy progesterone caproate and Placebo supplement; Assigned to Arm(s): 17P plus Placebo Supplement
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: N-Acetyl Cysteine | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: N-Acetyl Cysteine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
C: Arm Label: Cervical Pessary; Type: EXPERIMENTAL; Interventions: Device: Cervical pessary | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Cervical pessary; Assigned to Arm(s): Cervical Pessary
D: Intervention Type: DRUG; Name: Micronised progesterone (Utrogestan); Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial of Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in Pregnancies at High Risk
Brief Summary: A recently completed trial of weekly injections of 17 alpha hydroxyprogesterone caproate (17P) found significant effectiveness for 17P in preventing recurrent preterm birth. However, the group who received 17P in this trial still had a high rate of preterm birth. Several reports have shown that dietary supplementation of fish oil, which is rich in Omega-3 fatty acids, reduces the risk of preterm birth. This trial tests whether adding the Omega-3 supplement to 17P therapy has the potential for further reducing the risk of preterm birth in women who have previously had a spontaneous preterm delivery. The trial will compare Omega-3 fatty acid with placebo in women receiving 17P therapy. The hypothesis being tested is: "Among women at high risk for preterm birth receiving weekly injections of 17P, the addition of Omega-3 nutritional supplement will further reduce the rate of preterm birth."


Options:
A: Arm Label: DHA supplementation; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Docosahexanoic Acid | Arm Label: Soybean Oil; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Docosahexanoic Acid; Assigned to Arm(s): DHA supplementation | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Soybean Oil
B: Arm Label: Omega-3 Fish Oil; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Omega-3 Fish Oil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Omega-3 Fish Oil | Intervention Type: DIETARY_SUPPLEMENT; Name: Omega-3 Fish Oil; Assigned to Arm(s): Omega-3 Fish Oil, Placebo
C: Arm Label: 17P plus Omega-3 Supplement; Type: ACTIVE_COMPARATOR; Interventions: Drug: 17 alpha-Hydroxyprogesterone Caproate and Omega-3 supplement | Arm Label: 17P plus Placebo Supplement; Type: PLACEBO_COMPARATOR; Interventions: Drug: 17 alpha-hydroxy progesterone caproate and Placebo supplement | Intervention Type: DRUG; Name: 17 alpha-Hydroxyprogesterone Caproate and Omega-3 supplement; Assigned to Arm(s): 17P plus Omega-3 Supplement | Intervention Type: DRUG; Name: 17 alpha-hydroxy progesterone caproate and Placebo supplement; Assigned to Arm(s): 17P plus Placebo Supplement
D: Arm Label: 1; Type: OTHER; Interventions: Dietary Supplement: omega 3 fatty acids | Arm Label: 2; Type: OTHER; Interventions: Dietary Supplement: vegetable oil | Intervention Type: DIETARY_SUPPLEMENT; Name: omega 3 fatty acids; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: vegetable oil; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Patients With Idiopathic Membranous Nephropathy at Risk for Renal Insufficiency: Comparison of Early Versus Late Start of Immunosuppressive Therapy
Brief Summary: Patients with idiopathic membranous nephropathy at risk for renal failure can be identified in an early stage by measuring urinary low molecular weight proteins and urinary immunoglobulin G (IgG). This study evaluates the possible benefit of early start of immunosuppressive therapy in these high-risk patients.


Options:
A: Arm Label: late intervention; Type: OTHER; Interventions: Drug: Cyclophosphamide and steroids | Arm Label: early intervention; Type: EXPERIMENTAL; Interventions: Drug: Cyclophosphamide and steroids | Intervention Type: DRUG; Name: Cyclophosphamide and steroids; Assigned to Arm(s): early intervention, late intervention
B: Arm Label: prednisone; Type: N/A; Interventions: N/A | Arm Label: prednisone and anti-virus; Type: N/A; Interventions: N/A
C: Arm Label: Rituximab Treatment Arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Rituximab | Arm Label: Cyclosporine Treatment Arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cyclosporine | Intervention Type: DRUG; Name: Rituximab; Assigned to Arm(s): Rituximab Treatment Arm | Intervention Type: DRUG; Name: Cyclosporine; Assigned to Arm(s): Cyclosporine Treatment Arm
D: Arm Label: active comparator; Type: ACTIVE_COMPARATOR; Interventions: Drug: symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin) | Arm Label: experimental; Type: EXPERIMENTAL; Interventions: Drug: experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab) | Intervention Type: DRUG; Name: symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin); Assigned to Arm(s): active comparator | Intervention Type: DRUG; Name: experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab); Assigned to Arm(s): experimental

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled Sequential Clinical Trial of Sodium Valproate in ALS
Brief Summary: The purpose of this study is to determine whether the use of sodium valproate is effective in slowing the disease progression in Amyotrophic Lateral Sclerosis.


Options:
A: Intervention Type: DRUG; Name: Sodium Valproate; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: minocycline; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Thalidomide (drug); Assigned to Arm(s): N/A
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lithium Carbonate, Drug: Riluzole | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Riluzole, Drug: placebo | Intervention Type: DRUG; Name: Lithium Carbonate; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Riluzole; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Posttraumatic Stress Disorder in Kosovar High School Students Using Mind-Body Skills Groups: A Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine whether the participation in a group program which includes meditation, biofeedback, drawings, autogenic training, genograms, and a variety of movement and breathing techniques will decrease symptoms of posttraumatic stress in high school students.


Options:
A: Arm Label: Trauma-Focused Cognitive Behavioral Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Trauma-Focused Cognitive Behavioral Therapy | Arm Label: Waiting List Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Trauma-Focused Cognitive Behavioral Therapy; Assigned to Arm(s): Trauma-Focused Cognitive Behavioral Therapy
B: Arm Label: Mind-Body Skills Groups; Type: EXPERIMENTAL; Interventions: Behavioral: Mind-Body Skills Groups | Arm Label: Delayed Intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mind-Body Skills Groups; Assigned to Arm(s): Mind-Body Skills Groups
C: Arm Label: Psychosocial counseling; Type: N/A; Interventions: N/A | Arm Label: Medication; Type: N/A; Interventions: N/A
D: Arm Label: Waitlist+EducAid; Type: ACTIVE_COMPARATOR; Interventions: Other: EducAid educational programming | Arm Label: Waitlist; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: YRI only; Type: EXPERIMENTAL; Interventions: Behavioral: YRI, Other: EducAid educational programming | Arm Label: YRI+EducAid; Type: EXPERIMENTAL; Interventions: Behavioral: YRI, Other: EducAid educational programming | Intervention Type: BEHAVIORAL; Name: YRI; Assigned to Arm(s): YRI only, YRI+EducAid | Intervention Type: OTHER; Name: EducAid educational programming; Assigned to Arm(s): Waitlist+EducAid, YRI only, YRI+EducAid

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Posttraumatic Stress Disorder in Kosovar High School Students Using Mind-Body Skills Groups: A Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine whether the participation in a group program which includes meditation, biofeedback, drawings, autogenic training, genograms, and a variety of movement and breathing techniques will decrease symptoms of posttraumatic stress in high school students.


Options:
A: Arm Label: Early Childhood Development Program; Type: EXPERIMENTAL; Interventions: Behavioral: Early Childhood Development Program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Early Childhood Development Program; Assigned to Arm(s): Early Childhood Development Program
B: Arm Label: Psychosocial counselling + Enhanced usual care (EUC); Type: EXPERIMENTAL; Interventions: Behavioral: Psychosocial counselling, Other: Enhanced Usual Care | Arm Label: Enhanced Usual Care (EUC); Type: ACTIVE_COMPARATOR; Interventions: Other: Enhanced Usual Care | Intervention Type: BEHAVIORAL; Name: Psychosocial counselling; Assigned to Arm(s): Psychosocial counselling + Enhanced usual care (EUC) | Intervention Type: OTHER; Name: Enhanced Usual Care; Assigned to Arm(s): Enhanced Usual Care (EUC), Psychosocial counselling + Enhanced usual care (EUC)
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Psychosocial support training for school teachers | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Psychosocial support training for school teachers; Assigned to Arm(s): Intervention
D: Arm Label: Mind-Body Skills Groups; Type: EXPERIMENTAL; Interventions: Behavioral: Mind-Body Skills Groups | Arm Label: Delayed Intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mind-Body Skills Groups; Assigned to Arm(s): Mind-Body Skills Groups

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Posttraumatic Stress Disorder in Kosovar High School Students Using Mind-Body Skills Groups: A Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine whether the participation in a group program which includes meditation, biofeedback, drawings, autogenic training, genograms, and a variety of movement and breathing techniques will decrease symptoms of posttraumatic stress in high school students.


Options:
A: Arm Label: counseling intervention; Type: EXPERIMENTAL; Interventions: Behavioral: basic counselling by lay-health workers | Arm Label: Enhanced usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Enhanced usual care | Intervention Type: BEHAVIORAL; Name: basic counselling by lay-health workers; Assigned to Arm(s): counseling intervention | Intervention Type: OTHER; Name: Enhanced usual care; Assigned to Arm(s): Enhanced usual care
B: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced usual care | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: PRIDE 'Step 1' problem-solving intervention | Intervention Type: BEHAVIORAL; Name: PRIDE 'Step 1' problem-solving intervention; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Enhanced usual care; Assigned to Arm(s): Control
C: Arm Label: Integrated mental health in primary care; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated mental health in primary care | Arm Label: Psychiatric nurse-led specialist care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychiatric nurse-led specialist care | Intervention Type: BEHAVIORAL; Name: Integrated mental health in primary care; Assigned to Arm(s): Integrated mental health in primary care | Intervention Type: BEHAVIORAL; Name: Psychiatric nurse-led specialist care; Assigned to Arm(s): Psychiatric nurse-led specialist care
D: Arm Label: Mind-Body Skills Groups; Type: EXPERIMENTAL; Interventions: Behavioral: Mind-Body Skills Groups | Arm Label: Delayed Intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mind-Body Skills Groups; Assigned to Arm(s): Mind-Body Skills Groups

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Preventing Serious Neonatal and Maternal Peripartum Infections in Developing Country Settings With a High Prevalence of HIV Infection: Assessment of the Disease Burden and Evaluation of an Affordable Intervention in Soweto, South Africa
Brief Summary: The purpose of this study is to evaluate whether use of the disinfectant chlorhexidine administered to the birth canal during labour and newborn at delivery can protect a woman and her baby from bacterial infections after birth. If effective, this could be used as an inexpensive alternative to antibiotics to prevent newborn infections in resource-poor countries.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Chlorhexidine, Procedure: Birth canal wipe | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Procedure: sterile water external genital wipe | Intervention Type: DRUG; Name: Chlorhexidine; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Birth canal wipe; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: sterile water external genital wipe; Assigned to Arm(s): 2
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: CHX x 7 days | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: chx once | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: dry cord care | Intervention Type: BEHAVIORAL; Name: chx once; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: CHX x 7 days; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: dry cord care; Assigned to Arm(s): 3
C: Arm Label: Chlorhexidine; Type: EXPERIMENTAL; Interventions: Procedure: Chlorhexidine vaginal and infant wash | Intervention Type: PROCEDURE; Name: Chlorhexidine vaginal and infant wash; Assigned to Arm(s): Chlorhexidine
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: 4% Chlorhexidine | Arm Label: B; Type: EXPERIMENTAL; Interventions: Other: Hand washing Soap | Arm Label: C; Type: EXPERIMENTAL; Interventions: Drug: 4% Chlorhexidine | Arm Label: D; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: 4% Chlorhexidine; Assigned to Arm(s): A | Intervention Type: OTHER; Name: Hand washing Soap; Assigned to Arm(s): B | Intervention Type: DRUG; Name: 4% Chlorhexidine; Assigned to Arm(s): C

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Open Label, Phase I/II Trial of Rituximab Therapy for Steroid-Refractory Chronic Graft vs. Host Disease
Brief Summary: The purpose of this study is to determine if rituximab is a safe and effective therapy for steroid-refractory chronic graft versus host disease (GVHD).


Options:
A: N/A
B: Intervention Type: DRUG; Name: Rituximab; Assigned to Arm(s): N/A
C: Arm Label: ECP Methoxsalen + Standard of Care; Type: EXPERIMENTAL; Interventions: Drug: ECP Methoxsalen, Drug: Standard of Care | Arm Label: Standard of Care; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard of Care | Intervention Type: DRUG; Name: ECP Methoxsalen; Assigned to Arm(s): ECP Methoxsalen + Standard of Care | Intervention Type: DRUG; Name: Standard of Care; Assigned to Arm(s): ECP Methoxsalen + Standard of Care, Standard of Care
D: Intervention Type: DRUG; Name: Methoxsalen; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Extracorporeal Photopheresis; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Open Label, Phase I/II Trial of Rituximab Therapy for Steroid-Refractory Chronic Graft vs. Host Disease
Brief Summary: The purpose of this study is to determine if rituximab is a safe and effective therapy for steroid-refractory chronic graft versus host disease (GVHD).


Options:
A: N/A
B: Intervention Type: DRUG; Name: Rituximab; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Methoxsalen; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Extracorporeal Photopheresis; Assigned to Arm(s): N/A
D: Arm Label: Mycophenolate mofetil; Type: ACTIVE_COMPARATOR; Interventions: Drug: mycophenolate mofetil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: mycophenolate mofetil; Assigned to Arm(s): Mycophenolate mofetil | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo

Answer: B